Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cet article présente les recommandations de l'"European Society for Medical Oncology" (ESMO) et de l'"European Reference Network for Rare adulte solid Cancers" (EURACAN) sur le diagnostic, le traitement et le suivi d'un carcinome rhinopharyngé
- This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC)
- It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up
- Treatment algorithms for locoregional and recurrent/metastatic NPC are provided
- Recommendations were compiled by the authors based on available scientific data and the authors’ collective expert opinion
Annals of Oncology , résumé, 2020